Cargando…

Serum chemerin in patients with rheumatoid arthritis: can it unravel the Chimera of concomitant type 2 diabetes?

Detalles Bibliográficos
Autor principal:	Patoulias, Dimitrios Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477468/ https://www.ncbi.nlm.nih.gov/pubmed/32921834 http://dx.doi.org/10.5114/reum.2020.98439

Ejemplares similares

miRNA-122: Can it unravel an alternative pathway in early diagnosis and prognosis of type 2 diabetes mellitus?
por: Patoulias, Dimitrios Ioannis
Publicado: (2018)

Does a gluten-free diet determine the efficacy of sotagliflozin in patients with concomitant type 1 diabetes mellitus and celiac disease?
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2018)

Canakinumab: can it untie the Gordian knot of cardiovascular disease in patients with familial Mediterranean fever?
por: Patoulias, Dimitrios Ioannis
Publicado: (2018)

Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin?
por: Patoulias, Dimitrios Ioannis
Publicado: (2018)

Functional disability is related to serum chemerin levels in rheumatoid arthritis
por: Vazquez-Villegas, Maria Luisa, et al.
Publicado: (2021)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2018)

Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis
por: Mohammed Ali, Dunia M., et al.
Publicado: (2020)

Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Sexual dysfunction among women with systemic lupus erythematosus: might it reflect cardiovascular disease burden?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis
por: Gonzalez-Ponce, Fabiola, et al.
Publicado: (2021)

Febuxostat versus allopurinol for patients with gout: is it time to overcome concerns regarding cardiovascular safety?
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2021)

Hepatitis C virus infection and atherosclerotic cardiovascular disease: recent knowledge, further insights
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2020)

Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis
por: Kaneko, Kayoko, et al.
Publicado: (2011)

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2019)

Meckel’s diverticulum complications in three first-degree relatives: time to rethink familial predisposition?
por: Patoulias, Ioannis, et al.
Publicado: (2020)

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis
por: Lehane, P B, et al.
Publicado: (2014)

Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations
por: Patoulias, Dimitrios, et al.
Publicado: (2020)

Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association
por: Di Muzio, Claudia, et al.
Publicado: (2022)

Letter: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7)
por: Patoulias, Dimitrios, et al.
Publicado: (2019)

Safety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19
por: Dimosiari, Athina, et al.
Publicado: (2023)

COVID-19: A Chimera of Two Pandemics
por: Jabbari, Parnian, et al.
Publicado: (2020)

Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis
por: Tolusso, Barbara, et al.
Publicado: (2018)

Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
por: Patoulias, Dimitrios, et al.
Publicado: (2020)

Therapeutic versus prophylactic heparin for thromboprophylaxis in patients with COVID-19: weighing the costs and benefits. A rapid meta-analysis of randomized controlled trials
por: Dimosiari, Athina, et al.
Publicado: (2022)

Effect of COVID-19 on endothelial function evaluated with flow-mediated dilation: another prognostic marker? A meta-analysis of observational studies
por: Dimosiari, Athina, et al.
Publicado: (2022)

Evaluation of Serum Amyloid A as a Marker of Persistent Inflammation in Patients with Rheumatoid Arthritis
por: Agilli, Mehmet, et al.
Publicado: (2015)

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes
por: Westhrin, Marita, et al.
Publicado: (2018)

Can network biology unravel the aetiology of congenital hyperinsulinism?
por: Stevens, Adam, et al.
Publicado: (2013)

Concomitant laparoscopic procedures can be done for urological diseases
por: Wiwanitkit, Viroj
Publicado: (2010)

Association of the Adipokines Chemerin, Apelin, Vaspin and Omentin and Their Functional Genetic Variants with Rheumatoid Arthritis
por: Wahba, Alaa S., et al.
Publicado: (2021)

Endothelial dysfunction and COVID-19: What's the true impact on surrogate outcomes?
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes
por: Han, Juyoung, et al.
Publicado: (2016)

Rheumatoid Arthritis and Anti-Thyroid Antibodies
por: Yavasoglu, Irfan, et al.
Publicado: (2009)

Is miRNA-375 a promising biomarker for early detection and monitoring of patients with type 2 diabetes?
por: Patoulias, Dimitrios Ioannis
Publicado: (2018)

Using a periclinal chimera to unravel layer-specific gene expression in plants
por: Filippis, Ioannis, et al.
Publicado: (2013)

Association of the serum chemerin level with the development of diabetic retinopathy in patients with type 1 diabetes mellitus
por: Elmahdy, Ahmed Gomaa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_av4sj4amp7dp5f5vpng82oa646